Next steps in regulatory T cells: Biology and clinical application

Area of Science:

• Immunology
• Regenerative Medicine
• Translational Therapeutics

Background:

• Regulatory T cells (Tregs) are crucial for maintaining immune homeostasis and preventing autoimmune diseases.
• Recent breakthroughs in understanding Treg biology have opened new avenues for therapeutic interventions.
• Treg-based therapies are emerging as a promising strategy for immune-related disorders.

Purpose of the Study:

• To summarize key knowledge on Treg biology.
• To highlight recent discoveries in clinical applications of Tregs.
• To provide perspectives on research priorities and challenges for developing next-generation Treg therapies.

Main Methods:

• Review of recent scientific literature on Treg biology and clinical applications.
• Analysis of promising Treg-based therapeutic approaches, including low-dose interleukin-2 therapy, adoptive Treg transfer, and CAR Tregs.
• Identification of key research priorities and translational challenges.

Main Results:

• Treg-based treatments are positioned as a transformative therapeutic approach for immune-related disorders.
• Low-dose interleukin-2 therapy shows promise in trials for Amyotrophic Lateral Sclerosis (ALS).
• Adoptive Treg transfer demonstrates efficacy in preventing Graft-versus-Host Disease (GvHD), and CAR Tregs are in early pilot studies.

Conclusions:

• Tregs can act as a